Stocks / NASDAQ / Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

Our Opinion

Lexaria Bioscience Corp. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces positive findings in an animal study evaluating DehydraTECHTM processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil, for potential application in the management of erectile dysfunction.” Read the following article

Company Description

Lexaria Bioscience Corp. is a Canada-based global innovator in drug delivery platforms. The Company’s patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting oral delivery.

Company Website: